Partner David Rosen was quoted in an article published in Business Insider on April 18, 2014, titled “Why America Needs This Dangerous New Painkiller.” The article discusses Zohydro, a new hydrocodone painkiller, and the sharp criticism it has drawn because of the potential for abuse since it does not yet have tamper-resistant technology that would make it more difficult to crush and snort. Rosen was quoted saying, “”With respect to having a product available for use for chronic pain, when the drug is used appropriately, yes, this is a good call.”
People
Related News
04 October 2024
In the News
Rajiv Dharnidharka and Jeanette Barzelay Featured Across Legal Press for Move to Foley
Recent laterals Rajiv Dharnidharka and Jeanette Barzelay are featured across legal press for their arrival to Foley, including in the Law360 article, "Foley Adds 2 DLA Piper Business Litigators In San Francisco."
04 October 2024
In the News
Chanley Howell on AI IP Protection in Litigation – 'Judges are human'
Foley & Lardner LLP partner Chanley Howell shared insight on protecting the intellectual property behind emerging technologies like artificial intelligence in the Bloomberg Law article, "AI Put on Trial in ‘Life or Death’ Police Tech Clashes."
01 October 2024
In the News
Natasha Allen on DEI Challenges for Corporate Boards – 'Diversity is necessary for companies to succeed'
Foley & Lardner LLP partner Natasha Allen authored the article, "Navigating Today's DEI Challenges," in the November/December issue of Corporate Governance Advisor.